Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats

Nutrition

Volumn 24, Issue 5, 2008, Pages 470-476

  Yamamoto, Masaki ^a   Suzuki, Atsushi ^a   Jokura, Hiroko ^a   Yamamoto, Naoki ^a   Hase, Tadashi ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Endothelial dysfunction; Glucosyl hesperidin; Hypertension; Nicotinamide adenine dinucleotide phosphate oxidase; Nitric oxide; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVONE DERIVATIVE; GLUCOSYL HESPERIDIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITROPRUSSIDE SODIUM; SUPEROXIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; DEOXYGUANOSINE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSIDES; HESPERIDIN; HYPERTENSION; MALE; NADPH OXIDASE; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; VASODILATION;

RATTUS;

EID: 41549119823     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.01.010     Document Type: Article

References (29)

1. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 (2004) 1983-1992
2. Panza J.A., Casino P.R., Kilcoyne C.M., and Quyyumi A.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87 (1993) 1468-1474
3. Taddei S., Virdis A., Mattei P., and Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21 (1993) 929-933
4. Tesfamariam B., and Halpern W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 11 (1988) 440-444
5. Luscher T.F., and Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8 (1986) 344-348
6. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
7. Zalba G., Beaumont F.J., San José G., Fortuño A., Fortuño M.A., Etayo J.C., et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35 (2000) 1055-1061
8. Suzuki H., Swei A., Zweifach B.W., and Schmid-Schönbein G.W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 25 (1995) 1083-1089
9. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
10. Bazzano L.A., He J., Ogden L.G., Loria C.M., Vupputuri S., Myers L., et al. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nut 76 (2002) 93-99
11. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
12. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993) 1007-1011
13. Garg A., Garg S., Zaneveld L.J., and Singla A.K. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15 (2001) 655-669
14. Wilmsen P.K., Spada D.S., and Salvador M. Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53 (2005) 4757-4761
15. Galati E.M., Trovato A., Kirjavainen S., Forestieri A.M., Rossitto A., and Monforte M.T. Biological effects of hesperidin, a citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat. Il Farmaco 51 (1996) 219-221
16. Bok S.H., Lee S.H., Park Y.B., Bae K.H., Son K.H., Jeong T.S., et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 129 (1999) 1182-1185
17. Hijiya H., and Miyake T. Alpha-glycosyl hesperidin, and its preparation and uses (1991) European patent publication no. 0402049.
18. Yamada M., Tanabe F., Arai N., Mitsuzumi H., Miwa Y., Kubota M., et al. Bioavailability of glucosyl hesperidin in rats. Biosci Biotechnol Biochem 70 (2006) 1386-1394
19. Ohtsuki K., Abe A., Mitsuzuwi H., Kondo M., Uemura K., Iwasaki Y., et al. Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 48 (2002) 420-422
20. Ohtsuki K., Abe A., Mitsuzumi H., Kondo M., Uemura K., Iwasaki Y., et al. Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature. J Nutr Sci Vitaminol (Tokyo) 49 (2003) 447-450
21. Miwa Y., Mitsuzumi H., Sunayama T., Yamada M., Okada K., Kubota M., et al. Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol (Tokyo) 51 (2005) 460-470
22. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
23. G-nitro-L-arginine in rats. Am J Physiol Heat Circ Physiol 263 (1992) H1090-H1094
24. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
25. Kim J.Y., Jung K.J., Choi J.S., and Chung H.Y. Hesperetin: a potent antioxidant against peroxynitrite. Free Radic Res 38 (2004) 761-769
26. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96 (2005) 818-822
27. Touyz R.M., and Schiffrin E.L. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122 (2004) 339-352
28. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
29. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081